AX vs LMND

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline stable financial health, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics like a 50.8% operating margin and consistent earnings beats, weak revenue growth and lack of key financial data constrain confidence. The stock trades above the Graham Number of $88.69 at $91.75, implying a slight premium, but remains below the analyst target of $103.25. Bearish insider activity and a weak technical trend offset solid historical performance and favorable sector-relative valuation.

Lemonade exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe instability in fundamental health. While the company demonstrates impressive top-line revenue growth of 53.5%, it remains deeply unprofitable with a negative ROE of -29.37% and a negative profit margin. Insider sentiment is strongly bearish, characterized by significant selling from the CEO and CFO with zero buying activity. The current valuation represents a massive premium over book value (P/B 9.36), making the stock a high-risk speculative play despite recent price momentum.